← FDA DRUG APPROVALS

FDA ANDA · ANDA083266

AMNESTROGEN

Sponsor: BRISTOL MYERS SQUIBB

APPLICATION
ANDA083266
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

AMNESTROGENDiscontinued
ESTROGENS, ESTERIFIED 1.25MG · TABLET · ORAL
AMNESTROGENDiscontinued
ESTROGENS, ESTERIFIED 0.3MG · TABLET · ORAL
AMNESTROGENDiscontinued
ESTROGENS, ESTERIFIED 2.5MG · TABLET · ORAL
AMNESTROGENDiscontinued
ESTROGENS, ESTERIFIED 0.625MG · TABLET · ORAL
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →